Fludarabine

Human medicines European public assessment report (EPAR): Erivedge, vismodegib, Date of authorisation: 12/07/2013, Date of refusal: 26/04/2013, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 22, Status: Authorised

Podcast: Inside EMA

New product information wording: extracts from PRAC recommendations on signals adopted at the 7-10 July 2025 PRAC

First EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 November 2025, 09:00 (CET) to 5 November 2025, 17:00 (CET)

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 20 January 2026, 09:30 (CET) to 20 January 2026, 13:00 (CET)

European Union example instances - E2B(R3) testing files

Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 7, Status: Authorised